Drug User Health

overview

Since its founding in 1992, NASTAD members have been concerned about the role of drug use in the transmission of HIV and HCV, health outcomes for persons living with HIV and hepatitis who use drugs, and the structural and policy barriers to effectively address the prevention, care, and treatment needs of persons who inject drugs. To address the prevention, care, treatment, and policy needs related to drug user health, NASTAD has partnered with federal, state, and local governments and community partners to continue to advocate for a comprehensive response to these environmental crises to address this important population. In addition to partnerships with key organizations, NASTAD produces resources, provides technical assistance to our members and community-based harm reduction programs, and advocates for an effective science based public health approach to address the needs of people who inject drugs.

SIGN UP FOR THE HARM REDUCTION TA CENTER NEWSLETTER